Healthcare & Life Sciences
Chroma Therapeutics
United Kingdom
activeseries-c-plus
series-c-plus
Stage
2004
Founded
2
Investors
About
Chroma Therapeutics develops targeted therapies that enhance the precision and efficacy of cancer treatments by modulating DNA damage response pathways.
Explore Chroma Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.